Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers

Published: Wednesday, June 10, 2009
Last Updated: Wednesday, June 10, 2009
Bookmark and Share
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.

Phytronix Technologies Inc. and Agilent Technologies Inc. announced they have signed a non-exclusive co-marketing agreement to promote the Phytronix Laser Diode Thermal Desorption (LDTD) Ion Source with Agilent mass spectrometers.

The LDTD Ion Source, used with an Agilent MS/MS can offer ultra fast sample analysis for both quantitative and qualitative applications in high-throughput environments such as drug discovery processes (ADMET and DMPK), toxicology, forensics, food safety, and environmental applications.

The LDTD complements Agilent’s 1200 Series HPLC-Chip/MS. The latter provides on-line LC/MS at nanoflow rates that are well-suited to applications where sample amount is limited. The LDTD is based on a shotgun approach, which uses the separation power of the mass spectrometer for high throughput small molecule quantization in a myriad of applications.

Agilent and Phytronix have co-developed the interface between the LDTD and Agilent mass spectrometers to provide life science users with throughput that can exceed 20,000 samples per week.

Under the agreement, the companies will co-market the LDTD and Agilent mass spectrometer systems with each company responsible for its individual products. Agilent will sell and support its mass spectrometers and Phytronix will sell and support the LDTD and the interface between the LDTD and Agilent mass spectrometers. Each company will co-promote their products at industry tradeshows and conferences.

“The combination of the LDTD with Agilent mass spectrometers provides a powerful tool for life science researchers,” said Jean Lacoursiere, Phytronix’s President.

“In particular the LDTD combined with the new Agilent 6530 Accurate-Mass Q-TOF and 6460 Triple Quadrupole instruments provides researchers with exceptional sensitivity and analytical speed. This LDTD-Agilent mass spectrometer system allows, for example, pharmacokinetic studies in less than 10 minutes as well as enzyme inhibition trials in 18 minutes rather than the 10 hours presently required with current methods of analysis.”

Ken Miller, Global Sr. Marketing Manager for Mass Spectrometry at Agilent, added, “The Phytronix LDTD system will be very complementary to the Agilent nanoflow HPLC-Chip technology. The LDTD ion source offers some added capabilities such as a run-time of 4 seconds per sample for high throughput analysis. Many of our customers have asked for the integration of the Phytronix system with our 6000 Series LC/MS products, especially the Agilent 6400 Series Triple Quadrupole LC/MS/MS system.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent’s 2014 Early Career Professor Award Supports Biomedical Research
Dr. Paul Blainey recognized for work in single-cell measurement, analysis.
Saturday, May 24, 2014
Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
Project also seeks to develop better tools to test truth of seafood labels.
Monday, March 26, 2012
Agilent Technologies’ Exome Target-Enrichment System to Analyze 1,500 Samples in Erasmus Genetic Population Study
Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part to identify genetic risk factors for some complex genetic disorders.
Thursday, March 08, 2012
Agilent and Monash University Sunway Campus Collaborate
Latest technologies to strengthen university’s investigations into diabetes, cancer, neurobiology and infectious diseases.
Friday, December 09, 2011
Agilent and Oxford Gene Technology Expand Partnership
Agilent to provide OGT with oligonucleotide microarrays and SureSelect target enrichment products for sequencing.
Tuesday, October 18, 2011
Agilent Appoints Molecular Genomics as its First Certified Service Provider for Microarrays in Singapore
Molecular Genomics offers microarray services using the Agilent CGH/SNP microarrays, gene expression, and microRNA products.
Monday, July 25, 2011
Agilent Appoints NIMGenetics as Spain’s First Certified Service Provider for CGH and CGH/SNP Microarrays
NIMGenetics has achieved CSP status for genomic research using Agilent SurePrint comparative genomic hybridization and CGH/SNP microarrays.
Thursday, May 19, 2011
Agilent Appoints Beckman Coulter Genomics First CSP for Target Enrichment and Microarrays
Beckman now is certified to perform SureSelect target enrichment upstream of both the AB SOLiD and Illumina Genome Analyzer sequencers.
Monday, November 08, 2010
Agilent Technologies’ Microfluidics System Used in Breakthrough Breast Milk Study
Company’s HPLC-Chip and QTOF LC/MS technology provided researchers a new view of the oligosaccharide structures produced in breast milk.
Wednesday, August 18, 2010
Agilent Technologies Extends Million-Feature Format to Gene Expression Microarrays
Agilent SurePrint G3 Gene Expression Microarrays provides up to one million features per standard 1-by-3-inch slide for added throughput.
Tuesday, May 18, 2010
Agilent Microarray Manufacturing Achieves ISO 13485 Compliance; Cytogenetics Platform Poised to Pursue FDA 510(k) Clearance
Agilent Technologies Inc. today announced that its entire portfolio of DNA microarrays is now manufactured under ISO 13485 certification, an internationally recognized standard for quality management systems (QMS).
Thursday, March 25, 2010
Agilent Technologies Announces New Leadership in Biological Systems Division
Company appoints Robert Schueren as VP and GM of Genomics; and John Fjeldsted, Ph.D., as GM of LC/MS.
Wednesday, February 17, 2010
Institute for Systems Biology, Agilent Technologies to Build MRM Atlas for Quantification of All Human Proteins
The project is expected to fuel important research gains in biomarker discovery and validation, personalized medicine, and human health monitoring.
Monday, October 26, 2009
Dolan DNA Learning Center Adopts Agilent Lab-on-a-Chip System to Teach DNA Techniques
CSHL’s learning center adopts the Agilent 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA.
Friday, August 14, 2009
Agilent Technologies’ Custom-Designed CGH Microarray Used to Map Korean Genome
Scientists using an Agilent custom-designed comparative genomic hybridization array have sequenced the entire gene map of a Korean male.
Wednesday, July 22, 2009
Scientific News
Discovery Provides New Opportunities for Chips
Scientists at the University of Twente's MESA+ research institute have developed a new manufacturing method to create three-dimensional nanostructures.
Penn Engineering Team Showcases ‘Eye-on-a-Chip’ Technology
These small plastic chips contain microfluidic channels, carefully designed so that human cells can grow in them in a way that simulates the three-dimensional environments they would normally inhabit in the body.
Miniaturizable Magnetic Resonance
Microscopic gem the key to new development in magnetic lab-on-a-chip technology.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Stem Cell Research Hints at Evolution of Human Brain
Researchers at UC San Francisco have succeeded in mapping the genetic signature of a unique group of stem cells in the human brain that seem to generate most of the neurons in our massive cerebral cortex.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Smartphone App to Monitor Serious Blood Disorder
A researcher from Florida Atlantic University has come up with a unique way to monitor sickle cell disease -- a serious blood disorder -- using a smart phone.
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
‘Lab-on-a-Chip’ Technology Cuts Costs of Lab Tests
With ability to analyze minuscule amounts of fluid, Rutgers breakthrough could also promote central nervous system and joint research.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos